Very early researchUnknownNCT05480501
What this trial is testing
Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia
Who this might be right for
Leukemia
Beijing Immunochina Medical Science & Technology Co., Ltd. 9